Intrinsic Value of S&P & Nasdaq Contact Us

Acceleron Pharma Inc. XLRN NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
39/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$150.00
-16.1%

Acceleron Pharma Inc. (XLRN) has 19 known insider and institutional holders on record. The largest holder is CELGENE CORP /DE/ with 6,971,772 shares. Other notable holders include Kumar Ravindra and Quisel John D.

XLRN Insider Ownership

Top Holder
CELGENE CORP /DE/
6,971,772 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Celgene Corp /de/ 10 Percent Owner 6,971,772 2020-07-06
100%
2 Kumar Ravindra SVP & Chief Scientific Officer 86,986 2019-09-10
1%
3 Quisel John D EVP, Chief Business Officer 53,316 2020-01-03
1%
4 Rovaldi Christopher SVP, Program Mgmt and Ops 25,858 2018-04-04
0%
5 Backstrom Jay T. EVP, Research and Development 20,781 2021-02-02
0%
6 Kango Sujay EVP, Chief Commercial Officer 18,509 2021-09-27
0%
7 Zeldin Robert K EVP & Chief Medical Officer 13,000 2019-01-29
0%
8 Knopf John L CEO and President 12,500 2016-11-14
0%
9 Zakrzewski Joseph S Director 10,000 2021-04-02
0%
10 Maniatis Tom Director 7,500 2019-01-29
0%
11 Pops Richard F Director 7,500 2019-01-29
0%
12 George Jean Director 5,127 2020-01-24
0%
13 Nader Francois Director 3,222 2021-02-02
0%
14 Mccourt Thomas A Director 3,222 2021-02-02
0%
15 Kearney Terrence C Director 3,222 2021-02-02
0%
16 Mclaughlin Kevin F SVP, CFO and Treasurer 2,663 2021-09-24
0%
17 Mcguire Terrance Director 1,250 2017-03-14
0%
18 Hite Christopher Director 930 2021-02-02
0%
19 Hamill Laura Director 474 2021-02-02
0%

No ownership data available for XLRN.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message